5 employees
ExtremoChem develops small organic molecules, obtained exclusively by chemical synthesis, with protein stabilizing properties.
2013
$53K
from 1 investors over 1 rounds
Extremochem raised $53K on December 1, 2016
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)